Certara, Inc.

  • Moat Score
  • Safety Score
  • Market Cap $1.87B
  • PE -713
  • Debt $300.75M
  • Cash $179.09M
  • EV $1.99B
  • FCF $91.92M

Earnings

loading chart...

Sales & Net Margins

loading chart...
Earnings-$2.63M
EBIT$7.18M
ROE-0%
ROA0%
FCF$91.92M
Equity$1.08B
Growth Stability1
PE-713.29
PB1.73
P/FCF20.37
P/S4.75
Price/Cash0.1
Debt/Equity0.28
Debt/FCF3.27
Net Margins4%
Gross Margins60%
Op. Margins2%
Sales Growth YoY10%
Sales Growth QoQ6%
Sales CAGR11%
FCF CAGR14%
Equity CAGR16%
Earnings Growth YoY-201%
Earnings Growth QoQ-28%
Sales CAGR 5Y11%
FCF CAGR 5Y14%
Equity CAGR 5Y12%
Earnings CAGR 3Y7%
Sales CAGR 3Y7%
FCF CAGR 3Y-4%
Equity CAGR 3Y-0%
Market Cap$1.87B
Revenue$394.50M
Assets$1.56B
Total Debt$300.75M
Cash$179.09M
Shares Outstanding161M
EV1.99B
Moat Score34%
Safety Score91%
Working Capital192.1M
Current Ratio2.78
Gross Profit$237.72M
Shares Growth 3y1%
Equity Growth QoQ2%
Equity Growth YoY3%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...
Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory approval and increase patient access to medicines. The group has a business presence in the United States, EMEA and other regions, of which a majority of revenue is derived from the United States.

SEC Filings

Direct access to Certara, Inc. (CERT) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

  • 2025
    • 10-Q Mar 31
  • 2024
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31
  • 2023
    • 10-K Dec 31
    • 10-Q Sep 30
    • 10-Q Jun 30
    • 10-Q Mar 31

Sector Comparison

How does Certara, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Certara, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

loading chart...

Certara, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Certara, Inc..

= $2.5B
012345678910TV
fcf$92M$105M$120M$137M$156M$178M$203M$232M$265M$302M$345M$3.4B
DCF$95M$99M$103M$107M$111M$115M$119M$124M$128M$133M$1.3B
Value$2.5B

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years12/201912/202012/202112/202212/202312/2024TTM
Net Margins-4%-20%-5%4%-16%-3%4%
ROA--2%1%2%-3%-0%0%
ROE--6%-1%1%-5%-1%-0%

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years12/201912/202012/202112/202212/202312/2024TTM
Debt over FCF-6.915.123.33.673.823.27
Debt over Equity-0.370.290.280.280.280.28
Growth Stability------1

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years12/201912/202012/202112/202212/202312/2024CAGR 5Y
Revenue YoY growth-17%17%17%6%9%11%
Earnings YoY growth-453%-73%-211%-476%-78%-
Equity YoY growth-67%27%4%-3%1%12%
FCF YoY growth-22%35%54%-11%-3%14%